Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
Graham Belgrave• As an active member of ICR (Bourne End, UK) for more than 20 years and a clinical research consultant for Ipsen Ltd (Slough, UK), Graham Belgrave has been recognized as the 100th ICR Chartered Scientist.
Megan Sturm
• Praxis (Nashville, TN) has added Megan Sturm to its staff as the new business development manager, where she will oversee the company's activities in its Northeast United States and Southern California areas.
Emma Clayton
• With more than 10 years of conference and exhibition management experience, Emma Clayton has become ICR's (Bourne End, UK) new conference project manager.
• Covance (Princeton, NJ) has made several executive appointments, including Glynis Neagle, MD, as vice president for medical affairs; Robert Bader, PharmD, as director for product safety services; and Thomas Noto as vice president for regulatory affairs.
Glynis Neagle
• Richard Walovitch is WorldCare's (Boston, MA) new chief medical officer. He will bring with him over 20 years of management experience in preclinical and clinical development for therapeutics and diagnostics.
• Hans-Georg Eichler, MD, senior medical officer for the EMEA, has become the first non-U.S. regulatory liaison to the Clinical Trials Transformation Initiative Executive Committee. Dr. Eichler will fill the recently created nonvoting position.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.